Ruizhu Sun

Ruizhu Sun


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2022 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
RSRuizhu Sun
Ruizhu Sun
DHDan Huang
Dan Huang
ZLZhenxing Liu
Zhenxing Liu
TZTingting Zhu
Tingting Zhu
ZGZheyao Gu
Zheyao Gu
FXFangfei Xie
Fangfei Xie
Purpose. To evaluate the prevalence, causes, and risk factors of presenting visual impairment (PVI) and presenting blindness among adults in Suzhou, China. Methods. A total of 43927 subjects were included in this cross-sectional study. Each subject underwent ophthalmic examinations, including presenting visual acuity (PVA), intraocular pressure (IOP), slit-lamp examination, and fundus examination under the small pupils of each eye. Results. Using the World Health Organization (WHO) definition, the prevalence of bilateral PVI, bilateral presenting blindness, monocular PVI, and monocular presenting blindness was 1.59 (95 CI, 1.511.67), 0.002 (95 CI, 0.00190.0021), 3.87 (95 CI, 3.684.06), and 0.19 (95 CI, 0.180.20), respectively. Using the United States (US) definition, the prevalence of bilateral PVI, bilateral presenting blindness, monocular PVI, and monocular presenting blindness was 5.83 (95 CI, 5.546.12), 0.04 (95 CI, 0.0380.042), 7.43 (95 CI, 7.067.80), and 0.45 (95 CI, 0.430.47), respectively. The prevalence of PVI was higher in females (WHO criteria, 2.06, 95 CI, 1.962.16; US criteria, 7.27, 95 CI, 6.917.63) than in males (WHO criteria, 1.2, 95 CI, 1.141.26; US criteria, 4.65, 95 CI, 4.424.89). The leading cause of PVI is an uncorrected refractive error, followed by cataracts and age-related macular degeneration (AMD). Multivariate analysis proved that the prevalence of visual impairment (PVA, better eye, WHO criteria) increased significantly with older age, higher mean arterial pressure (MAP), higher globulin level, and higher fasting blood glucose (FBG). In addition, it also increased significantly with lower hemoglobin, a lower body mass index (BMI), and a lower arterial stiffness index. In this study, serum creatinine, blood urea nitrogen, uric acid, triglycerides, and the systemic immune-inflammation index (SII) showed no association with visual impairment. Conclusion. The leading causes of PVI in Suzhou were uncorrected refractive error and cataracts. The prevalence of PVI increased with females, older age, higher MAP, higher FBG, higher globulin, lower hemoglobin, lower BMI, and lower arterial stiffness index.

26 June 2024 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
YZYong Zhang
Yong Zhang
JSJiandong Su
Jiandong Su
YLYunfeng Liu
Yunfeng Liu
RSRan Sun
Ran Sun
RSRuizhu Sun
Ruizhu Sun
Background: Burns are a prevalent form of unintentional injury and a significant public health concern in developing countries. We aimed to investigate the epidemiological and clinical characteristics of adult burn patients at a major center in Eastern China.Methods: This 6-year retrospective study analyzed patients with varying degrees of burns between January 2017 and December 2022 at the Suzhou Burns and Trauma Center. The study extracted demographic, clinical, and epidemiological data from electronic medical records for analysis.Results: The study included 3,258 adult patients, of which 64.3% were male. The largest age group affected 30–59-year-old adults (63.04%). Scalds were the leading cause of burns (1,346, 41.31%), followed by flames (1,271, 39.01%). The majority of burn hospitalizations were those with moderate burns (1791, 54.97%). The morbidity rate was low at 0.68%, while mortality was strongly associated with age, etiology, and total body surface area. Patients with certain types of burns, such as explosions, hot crush injuries, and electric burns had more operations, longer lengths of hospital stay, and higher costs compared to those with scalds and flame injuries.Conclusion: Different prevention strategies should be formulated according to different etiologies, ages, and genders.

15 December 2024 in International Wound Journal
Verified
Journal Article
Open access
YZYong Zhang
Yong Zhang
JSJiandong Su
Jiandong Su
YLYunfeng Liu
Yunfeng Liu
RSRan Sun
Ran Sun
RSRuizhu Sun
Ruizhu Sun
Severe burns lead to malformations and higher mortality and have long‐term social consequences. We aimed to analyse the epidemiologic characteristics and clinical outcomes of severe burn patients hospitalized in a major burn centre in Eastern China. This study included severe burns patients hospitalized in our hospital from 2017 to 2022. We extracted all data from electronic medical records for retrospective analysis. Burn scoring systems were calculated for all patients. The median age of the patients was 49.00 years, with 62.13% of them aged between 30 and 59 years. Of the 375 adult patients, 256 were male and 119 were female. The major cause of burns was flame (46.1%), followed by explosion (35.2%). The median total body surface area was 40%. Sixty‐three percent of patients suffered an inhalation injury and 125 patients (33.3%) developed complications during hospitalization. The average mortality was 5.3%. Higher mortality rates are associated with advanced age, flame burns, larger full‐thickness burns area and total body surface area, inhalation injuries and combined burn complications. Severe burns often occur in middle‐aged men. Governments and companies need to improve the safety of living and working environments. It is essential to develop treatment strategies based on risk factors for burn deaths and improve the quality of medical care.

20 March 2025 in PLOS ONE
Verified
Journal Article
Open access
ZGZheyao Gu
Zheyao Gu
XLXiangying Luo
Xiangying Luo
RSRuizhu Sun
Ruizhu Sun
TXTing Xi
Ting Xi
CZChunyuan Zhang
Chunyuan Zhang
Background: Timely anti-vascular endothelial growth factor (VEGF) therapy is essential for visual function in neovascular age-related macular degeneration (nAMD). The coronavirus pandemic has led to unprecedented delays in anti-VEGF intravitreal therapy because of the need to reduce hospital attendance. Objectives: To assess the long-term impact of COVID-19 pandemic-related delays in intravitreal anti-VEGF therapy on nAMD patients. Methods: This was a retrospective study of 98 patients (102 eyes) with nAMD whose anti-VEGF treatments were interrupted for > 8 weeks due to the COVID-19 pandemic. Best-corrected visual acuity (BCVA), central retinal thickness (CRT) and anatomical characteristics on spectral domain optical coherence tomography (SD-OCT) were measured at baseline, at the last follow-up visit before treatment interruption (V0), at the first visit after the COVID-19 lockdown had ended (V1), at the six-month follow-up (V-6 months) and at the final visit at the 1-year follow-up (V-final). The control group included nAMD patients who had completed at least three anti-VEGF treatments and received consecutive follow-up with timely anti-VEGF treatments for one year. Results: After one year of regular follow-up and standardized treatment, the treatment-interrupted group (TIG) had significantly worse visual acuity than the treatment-continuous group (TCG) (0.71 ± 0.38 vs. 0.52 ± 0.32, p < 0.001); however, there was no significant difference between the groups in the mean CRT (273.95 ± 112.96 µm vs. 261.43 ± 90.66 µm, p > 0.05). Furthermore, subgroup analysis revealed that, compared with those before treatment interruption, the BCVA of the TIG patients slightly improved, but the mean CRT and related activity indices returned to baseline values according to OCT imaging (all p > 0.05). Multiple linear regression analysis revealed that longer treatment interruption was associated with greater deterioration in visual acuity (p = 0.009). Conclusion: Treatment interruption for more than 8 weeks had a sustained negative impact on visual acuity in treated eyes one year later. For nAMD patients, continuous treatment, regardless of the underlying regimen, remains critical.